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Abstract
Background: Depressive symptoms and memory problems are significant risk factors for dementia. Exercise can reduce
depressive symptoms and improve cognitive function in older people. In addition, the benefits of horticultural activity
on physical and mental well-being have been demonstrated in people with dementia. Although evidence of such
non-pharmacological interventions is mounting, no studies have examined whether physical exercise and horticultural
activity exert a positive impact on brain and mental health (e.g., depressive symptoms) in non-demented older adults at
high risk of cognitive impairment and depression. Therefore, we propose a randomized controlled trial to assess the efficacy
and efficiency of physical exercise and horticultural activity in improving brain and mental health in community-dwelling
older adults with memory problems and depressive symptoms.
Methods/Design: The 20-week randomized controlled trial will include 90 community-dwelling adults aged 65 years
or older with memory problems and depressive symptoms. Participants will be randomized to one of three experiments:
exercise, horticultural activity, or educational control group, using a 1:1:1 allocation ratio. The combined exercise program
and horticultural activity program will consist of 20 weekly 90-minute sessions. Participants in the exercise group will practice
aerobic exercise, muscle strength training, postural balance retraining, and dual-task training. The horticultural activity
program will include crop-related activities, such as field cultivation, growing, and harvesting. Participants in the educational
control group will attend two 90-minute educational classes during the 6-month trial period. Depressive symptoms and
memory performance will be measured by the Geriatric Depression Scale-15, and the Logical Memory subtests of the
Wechsler Memory Scale-Revised will be used to measure depressive symptoms and memory performance as primary
outcomes, at baseline (prior to randomization), immediately following intervention (6 months from baseline), and 6 months
after intervention. Hippocampal volume will be measured at baseline and immediately after intervention, using magnetic
resonance imaging. Secondary outcomes will comprise cognitive function, including language, attention/executive
performance, and processing speed; brain-derived neurotrophic-factor serum levels; and health-related quality of life.
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Discussion: This intervention study will determine the clinical importance and efficacy of physical exercise and
horticultural activity as non-pharmacological interventions in community-dwelling older adults at high risk of poor
brain and mental health.
Trial registration: UMIN000018547; registered 7 August 2015.
Keywords: Cognition, Depression, Exercise, Hippocampal volume, Horticulture
Background
Depressive symptoms constitute a significant risk factor for
Alzheimer’s disease (AD) [1]. Epidemiological studies have
reported an association between depressive symptoms and
cognitive decline, and depressive symptoms have been
shown to predict cognitive decline in old age [2–4]. Several
factors affect cognitive functioning in old age, and older
people with memory problems are considered to be at a
higher risk of developing dementia, particularly AD, rela-
tive to those without memory problems [5, 6]. In addition,
cognitive impairment is more common in older people
with depression [7]. Therefore, older adults with combined
memory decline and depressive symptoms may be at a
higher risk of dementia, and they should be the focus of in-
terventions designed to improve brain and mental health
and address issues such as memory problems and depres-
sive symptoms.
Exercise can improve cognitive function and reduce
depressive symptoms in older people. Specifically, aerobic
exercise has been shown to produce mild-to-moderate
cognitive gains in healthy adults [8]. Cognitive improve-
ment has also been observed following aerobic exercise in
older adults with mild cognitive impairment (MCI) [9, 10].
However, evidence concerning the effects of aerobic exer-
cise on memory in older adults with a higher risk of cogni-
tive impairment is limited [11]. Some studies have shown
memory improvement following exercise interventions in-
volving physical and cognitive activities in participants with
MCI [12, 13]. Interestingly, moderate-intensity physical ex-
ercise may increase hippocampal volume in cognitively
healthy community-dwelling older adults [14] and those
with MCI [15]. Hippocampal volume is the primary deter-
minant of memory decline [16], and geriatric depression
magnifies hippocampal atrophy and the risk of AD [17].
Exercise could also improve mood in older people.
Antidepressant effects have been observed with exercise
in people with mild depression [18]. A systematic review
indicated that exercise was moderately more effective
than a control intervention in reducing symptoms of de-
pression, but analysis of methodologically robust trials
showed a smaller effect in favor of exercise [19]. Results
of another review were consistent with the suggestion
that, for older people who present with clinically mean-
ingful symptoms of depression, prescribing structured
exercise with mixed elements of endurance and strength
training tailored to individual ability is likely to reduce
the severity of depression [20].
Another non-pharmacological intervention strategy for
reducing depression is horticultural activity, which is ex-
pected to increase social and behavioral activation and
mental well-being, and moderate levels of physical activity
in a nature-based environment [21]. In addition, interven-
tion studies, randomized controlled trials (RCTs), and
pre–post design studies have been conducted to examine
the effects of horticultural activity on physical and
mental well-being in people with dementia, and the re-
sults showed reductions in levels of agitation [22].
However, the quantitative studies were of poor quality
with respect to sample size and study design. In addition,
there have been no well-designed intervention studies
conducted to examine the effects of horticultural activity
on brain and mental health (e.g., depressive symptoms,
cognitive function, and brain volume) in non-demented
adults with a higher risk of dementia.
We hypothesize that physical exercise and horticultural
activity may exert a positive impact on brain (e.g., cognitive
function and brain volume in the hippocampus) and men-
tal health (e.g., depressive symptoms) in older adults with a
higher risk of cognitive impairment and depression. How-
ever, this hypothesis has not been tested. Therefore, we
propose a 20-week RCT involving community-dwelling
adults aged 65 years or older with mild memory problems
and depressive symptoms. Further, we aim to explore the
relative importance of hippocampal volume changes with
respect to improvements in cognitive function and mood.
Given the immense health and financial burdens imposed
by dementia and depression, the results of our pro-
posed RCT could exert a significant impact on the health of
Japanese seniors and the country’s long-term care system.
Methods/Design
Study design
The proposed study is a randomized single-blind con-
trolled community-based trial with a parallel design
and a 1:1:1 allocation ratio. The study design is shown
in Fig. 1. We will recruit 90 community-dwelling adults
aged 65 years or older with memory problems and de-
pressive symptoms. Informed consent will be obtained
from all participants prior to their inclusion in the
study. The study protocol was approved by the Ethics
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Committee of the National Center for Geriatrics and
Gerontology (#839).
Setting
This study will be conducted in the Japanese community
in Obu city, a suburb of Nagoya, Japan. Obu city has a
population of 88,550, of whom 17,354 (19.6 %) are aged
65 or older (in April 2014). We have been conducting an
observational study, including face-to-face interviews and
measures of physical and cognitive function, in this
community since 2011 [23]. Pre-intervention and post-
intervention participant screening and data collection will
be performed at the community center. Magnetic reson-
ance imaging (MRI) scanning will be conducted at the
Research Institute at the National Center for Geriatrics
and Gerontology.
Study population
The study population will include community-dwelling
older adults with mild memory decline and depressive
symptoms. Participants will be required to meet the fol-
lowing inclusion criteria: (1) independent adults aged
65 years or older living within the community; (2) memory
problems (subjective memory complaints or objective mild
memory decline indicated via an age-adjusted word list
memory score at least 1.0 SD below the reference thresh-
old); and (3) presence of depressive symptoms (Geriatric
Depression Scale-15 [GDS-15] score of ≥5) [24]. Partici-
pants will be excluded if they meet the following exclusion
criteria: (1) support or care certified by the Japanese public
long-term care insurance system; (2) dementia diagnosis or
Mini-Mental State Examination score of ≤18; (3) a history
of major psychiatric illness (e.g., bipolar disorder) or other
serious neurological or musculoskeletal diagnoses; (4)
disability in basic activities of daily living; (5) incapable of
undertaking cognitive performance tests; (6) physical exer-
cise contraindication; and (7) use of walking aids in daily
life. Participants will also be excluded if they cannot sign
the informed consent form.
Sample size
The required sample size for this study was calculated
using predictions of 6-month changes in GDS-15 results.
Based on the results of our previous work, conducted in
the same town, we predict that a change of 1.5 GDS-15
points would indicate differences and assume that the SDs
for the GSD-15 would be 2.5 in our sample. Assuming a
non-consent and dropout rate of 20–30 %, 30 participants
are required per group. The study design necessitates
power of at least 80 % and an α level of <.05 to assess the
effects of the interventions.
Randomization
Participants will be randomly assigned (1:1:1) to an exer-
cise intervention (EI), a horticultural intervention (HI), or
an educational (control) group upon completion of base-
line assessments. The randomization sequence will be
computer generated [25, 26]. A researcher who is unaware




The combined exercise program will involve 20 weekly
90-minute sessions involving physical and cognitive ac-
tivities. Approximately 10–15 individuals will participate
in each class at a fitness facility. Trained instructors will
conduct the exercise sessions, which will involve aerobic
Fig. 1 Overview of the flow of participants
Makizako et al. Trials  (2015) 16:499 Page 3 of 7
exercise, muscle strength training, postural balance retrain-
ing, and dual-task training. Each session will begin with
a 10-minute warm-up period and stretching exercises
followed by 20 minutes of muscle strength exercise and
postural balance retraining. The exercises will be con-
ducted under multitask conditions that will include
physical and cognitive tasks; we have called this com-
bination training “cognicize.” For example, participants
play word games while engaging in stepping exercises.
The participants will also undertake daily home-based ex-
ercises and walking, which will require self-monitoring
using a booklet and pedometer. To improve health behav-
ior, physiotherapists will deliver lectures to inform the par-
ticipants about cognitive health, exercise methods, the
risks associated with dementia, effects of exercise on de-
mentia, and ways in which to self-monitor regular physical
activities.
Horticultural intervention group
The HI program will involve 20 weekly 90-minute ses-
sions involving nature-based activities. The program will
include crop-related activities such as cultivating a field,
growing, and harvesting. Individuals in this group will
engage in gardening activities including group planting
(known as Yoseue style bonsai), which involves the com-
bination of different plant varieties or shapes, and plant-
ing flowers in the public garden. The vegetable experts
will lecture the participants with nutritional information
and recipes for the field crops that will be grown in the
program.
Educational control group
Participants in the educational control group will attend
two 90-minute education classes during the 6-month trial
period. The classes will include topics that experts con-
sider less likely to influence study outcomes (e.g., effective
remedies for crime or traffic accidents in older people).
Outcomes
Outcomes will be measured at the community center by
research assistants who are blinded to the randomization
status. Participants will be required to take part in baseline
data collection lasting approximately 2 hours. Subsequent
data collection will occur immediately following the inter-
vention (6 months after baseline) and 6 months after
intervention for all outcomes. All outcome measures will
be assessed by independent examiners who are unaware
of group allocation.
Primary outcomes
Primary outcomes will include a reduction in depressive
symptoms, based on changes in GDS-15 scores, and an
improvement in memory performance, assessed via word
list memory [27] and the Logical Memory subtests of the
Wechsler Memory Scale-Revised (WMS-R) [28]. The
GDS-15 consists of 15 items. A score of 5 or higher will
be used to identify clinical depressive symptoms [29, 30].
The word list memory tasks will involve immediate
recognition and delayed recall of a 10-word target list
[27]. Participants are instructed to memorize 10 words,
which are presented on a tablet personal computer. Each
of the 10 target words is presented for 2 seconds. A total
of 30 words, including 10 target and 20 distracter words,
is then presented, and participants are asked to choose
the 10 target words immediately (Word-List Memory Task
I); this is repeated for three trials. The average number of
correct answers is calculated to produce a score within a
range of 0–10. In addition, participants are instructed to
recall (and record in writing) the 10 target words after ap-
proximately 20 minutes (Word-List Memory Task II). The
total number of target words recalled is then calculated.
In the WMS-R Logical Memory subtests, two short stor-
ies (A and B) are read aloud to the participant, who is
instructed to recall the details of the stories immediately
(Logical Memory Task I) and after 30 minutes (Logical
Memory Task II) [28]. Total scores are calculated (i.e., sum
of scores for stories A and B) for WMS-R Logical Memory
Tasks I and II.
Secondary outcomes
Secondary outcomes will include whole-brain and hippo-
campal volume, evaluated using MRI; cognitive function,
assessed using verbal fluency tests (VFTs) [31] and tablet
versions of the trail-making test (TMT) [27] and symbol
digit substitution test (SDST) [27]; brain-derived neuro-
trophic factor (BDNF) serum levels; and health-related
quality of life (QOL).
Whole-brain and hippocampal volume will be deter-
mined using a 3-T system (TM Trio, Siemens, Germany).
Three-dimensional volumetric acquisition of a T1-weighted
gradient echo sequence will be performed to produce a
gapless series of thin sagittal sections using a magnetization
preparation rapid-acquisition gradient-echo sequence (in-
version time [TI] 800 ms; repetition time [TR] 1800 ms;
echo time [TE] 1.98 ms; and 1.1 mm slice thickness). Axial
T2-weighted spin-echo images (TR 4200 ms; TE 89.0 ms;
and 5.0 mm slice thickness) and axial fluid-attenuated
inversion-recovery images (TI 2500 ms; TR 9000 ms; TE
100 ms; 5 mm slice thickness) will then be obtained for
diagnosis.
Verbal fluency will be assessed according to the number
of words generated across 60-second trials [32]. Both the
letter VFT (which assesses phonemic verbal fluency) and
the animal naming test (which assesses semantic verbal
fluency) will be performed. In the letter VFT, participants
will be instructed to retrieve as many words (excluding
proper names) as possible within a 60-second period,
beginning with the Japanese syllabic characters (hiragana)
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“Shi,” “I,” and “Re” [33]. The total number of words gener-
ated for all three letters will be used as a measure of
performance. In the animal naming test, participants will
be instructed to generate a list of animal names within
60 seconds [31]. The tablet version of the TMT, consisting
of parts A and B, will be used to determine attention
and executive function [27]. In the tablet version of the
TMT-A, participants are required to touch target num-
bers (1–15), which are presented randomly on the
panel, in consecutive order as rapidly as possible. In the
tablet version of the TMT-B, participants touch target
numbers or letters, alternating between consecutive num-
bers and letters (Japanese Kana characters). We will record
the time (in seconds) taken to complete each task; a
shorter time represents superior performance. In the tablet
version of the SDST, nine pairs of numbers and symbols
are presented at the top of the display, and a target symbol
is shown in the center of the display. Participants then
choose a number that corresponds to a target symbol,
which is presented at the bottom of the display, as rapidly
as possible. The number of correct numbers chosen within
90 seconds constitutes the score. One point is awarded for
each number that is chosen correctly within the time limit.
The tablet versions of the TMT and SDST have demon-
strated reliability and validity in a sample of community-
dwelling older adults [27].
Serum BDNF levels will be measured using the
Quantikine Human Kit (R & D Systems, Inc. Minneapolis,
MN, USA) and used as a biomarker [12].
Health-related QOL will be assessed using the Short-
Form Health Survey-12, a standardized instrument with
established psychometric validity, which measures eight
health domains: physical functioning, role limitations
due to physical health, bodily pain, general health, vital-
ity (energy/fatigue), social functioning, role limitations
due to emotional health, and mental health (psycho-
logical distress and wellbeing) [34].
Other outcomes
Other outcomes will include physical performance tests
such as handgrip strength, walking speed, and the two-
minute walking test [35]; social network, assessed using
the abbreviated version of the Lubben Social Network
Scale (LSNS-6) [36]; Life-Space Assessment (LSA) [37];
subjective sleep quality, assessed using the Pittsburgh
Sleep Quality Index [38]; and daily physical activity level,
assessed using a triaxial accelerometer [39]. We will
monitor adherence to the intervention programs and
record adverse events.
Physical performance tests will include handgrip strength
to measure muscle strength, normal and maximum walk-
ing speed to measure general gait ability, and the two-
minute walking test to assess exercise tolerance. Handgrip
strength and walking speed are simple, easy to implement
in community settings, and strong predictors of health out-
comes [40]. In the two-minute walking test, participants
will be asked to walk, covering as much ground as possible
in a demarcated area within 2 minutes. The distance
walked within 2 minutes will be measured [35].
Social network will be measured using the LSNS-6,
which is a six-item scale (simple sum scoring with a range
of 0–30) consisting of three items that evaluate kinship ties
and three items that evaluate non-kin ties [36]. Life-space
mobility will be measured via the LSA, which is used to
obtain a score based on the reported distance travelled
during the 4 weeks preceding assessment. Scores range
from 0 (“totally roombound”) to 120 (“travelled out of
town every day without assistance”), with lower scores
reflecting lower life-space mobility [37, 41]. Sleep quality
will be evaluated using the Pittsburgh Sleep Quality Index,
which consists of 19 items that produce a global sleep
quality score and scores for the following seven compo-
nents: sleep quality, latency, duration, disturbance, habitual
sleep efficiency, use of soporific medication, and daytime
dysfunction. The sum of these seven component scores
yields one global score for subjective sleep quality (range
0–21), with higher scores reflecting poorer subjective sleep
quality [42]. Daily physical activity level, including duration
of light, moderate, and total physical activity, and the num-
bers of steps taken during the 2-week periods subsequent
to pre-intervention and post-intervention assessments, will
be measured using a triaxial accelerometer [39].
Statistical analyses
Statistical analyses will be conducted to assess the effects
of interventions according to the intention-to-treat
principle, which states that data for all individuals should
be analyzed according to their group allocation, regardless
of compliance. Data will be entered according to a multiple
imputation method. Between-group differences in primary
outcomes subsequent to intervention will be compared
using multiple linear regression analysis. Baseline scores,
experimental groups, and characteristics (e.g., age, sex,
diagnoses, and medical conditions) will be included in the
models as covariates. If the effects of the intervention are
significant, two planned simple contrasts will be performed
to assess differences between the EI and control groups
and the HI and control groups. Contrasts will also be
performed within each intervention group to determine
whether intervention benefits are observed for the primary
outcomes. The analysis performed for the primary out-
comes will also be performed for the secondary and other
outcome measures.
Discussion
This RCT will determine the clinical importance and effi-
cacy of non-pharmacological interventions in community-
dwelling older adults at a higher risk of poor brain and
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mental health, with MRI data and biomarkers used to as-
sess the biological mechanisms of action in multidimen-
sional exercise and horticultural activity.
Improved understanding of the primary mechanisms
underlying exercise and horticultural activity would
increase our capacity to refine and develop non-
pharmacological interventions for dementia and depression
prevention in the aging population. If interactions between
memory improvement, brain atrophy control, and depres-
sion reduction are clarified, these results could make a
major contribution to knowledge in this field.
One of strengths of our study is that the findings could
easily be translated into evidence-based intervention strat-
egies that both professionals and the lay public could use
to engage older adults in exercise and horticultural activ-
ity. If this study provides evidence of a potential treatment
that could increase brain health, including improvements
in cognitive function and mental health and reductions in
brain atrophy, our findings could be used immediately as
non-pharmacological interventions for dementia and de-
pression prevention in the community.
Trial status
At the time of manuscript submission, we have obtained
ethical approval, registered the trial, and successfully
recruited 29 participants, and the status of the trial is open
for enrollment.
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